Please Wait
Applying Filters...
menu
    • menu
    Mix Gif-PSE
    News
    Zydus Receives USFDA Tentative Approval For Dapagliflozin Tablets

    05 Feb 2026

    // EXPRESSPHARMA

    Lupin Introduces Topiramate Extended-Release Capsules In US

    05 Feb 2026

    // PRESS RELEASE

    AstraZeneca Wins CDSCO Nod for Durvalumab in Gastric Cancer

    05 Feb 2026

    // ECONOMICTIMES

    Data Compilation
    #PharmaFlow

    Amsa

    Contact Supplier

    Website

    Paris Packaging Week

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-opoe
    Menu

    Amsa

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2AMSA (Anonima Materie Sintetiche & Affini) S.p.A.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    PharmaSynergy
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-02-20

    Amsa

    City : Como

    State :

    Country/Area : Italy

    Zip :

    District : ORA

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2015-02-20

    Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    PharmaSynergy
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2013-03-22

    Amsa

    City : Como

    State :

    Country/Area : Italy

    Zip :

    District : ORA

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2013-03-22

    Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Amsa and get a quotation

    Amsa is a supplier offers 18 products (APIs, Excipients or Intermediates).

    Find a price of Flecainide bulk with DMF, CEP, JDMF offered by Amsa

    Find a price of Meloxicam bulk with DMF, CEP, JDMF offered by Amsa

    Find a price of Metoclopramide Hydrochloride bulk with CEP, JDMF offered by Amsa

    Find a price of Amantadine Hydrochloride bulk with DMF offered by Amsa

    Find a price of Etodolac bulk with DMF offered by Amsa

    Find a price of Glipizide bulk with DMF offered by Amsa

    Find a price of Glycopyrronium Bromide bulk with DMF offered by Amsa

    Find a price of Levodropropizine bulk with CEP offered by Amsa

    Find a price of Lurasidone Hydrochloride bulk with DMF offered by Amsa

    Find a price of Memantine Hydrochloride bulk with DMF offered by Amsa

    Find a price of Metoclopramide bulk with JDMF offered by Amsa

    Find a price of Bromhexine Hydrochloride bulk offered by Amsa

    Find a price of Etodolac bulk offered by Amsa

    Find a price of Glipizide bulk offered by Amsa

    Find a price of Imepitoin bulk offered by Amsa

    Find a price of Meloxicam bulk offered by Amsa

    Find a price of Oxantel Pamoate bulk offered by Amsa

    Find a price of Viloxazine Hydrochloride bulk offered by Amsa

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.